Gonorrhoea Vaccine Rollout for Gay and Bisexual Men in Northern Ireland

[andy]

Northern Ireland is set to make a significant stride in public health, following the Department of Health's approval of a pioneering gonorrhoea vaccination programme. This decisive move comes hot on the heels of England's announcement to become the world's first nation to roll out such a vaccine, hailed as a "landmark moment for sexual health" globally.

The Northern Ireland health department has confirmed that the vaccination effort against gonorrhoea will kick off this August. Initially, the jab will be prioritised for gay and bisexual men with a recent history of multiple sexual partners or a sexually transmitted infection (STI) – those deemed most vulnerable to contracting the infection.

Northern Irish Health Minister Mike Nesbitt issued a strong call to action, urging all eligible individuals to come forward and get vaccinated. "With gonorrhoea cases soaring, the launch of this world-first vaccine programme is not just important, but incredibly timely for Northern Ireland’s public health," he stated.

"By meticulously targeting those at greatest risk, we have a golden opportunity to stem the tide and dramatically reduce transmission rates of this complex disease, potentially averting thousands of cases over the coming years. STIs aren't merely an inconvenience; they can profoundly impact your health and that of any sexual partners. If you're offered this vaccine, I wholeheartedly encourage you to take it – it's a vital step to protect yourself and others."

The Alarming Rise of Gonorrhoea
Gonorrhoea remains the most prevalent STI diagnosed in Northern Ireland's sexual health clinics. Figures from the Public Health Agency (PHA) paint a stark picture: cases skyrocketed from 652 in 2021 to a staggering 1,606 in 2022 – the highest number ever recorded by the PHA.

Even in 2023, the trend remained concerning, with 1,561 gonorrhoea cases accounting for almost a third (28%) of all new STI diagnoses across the region. A significant majority of these cases (75%) were male, with gay, bisexual, and other men who have sex with men (gbMSM) making up 67% of that demographic.

A Critical Defence Against Evolving Resistance
This crucial vaccination programme, also slated to begin in England this August, emerges amidst grave warnings that some gonorrhoea strains are developing resistance to conventional treatments. The initial focus will be on gbMSM with a history of multiple sexual partners or an STI, alongside other at-risk individuals, including sex workers.

The vaccine itself is an existing jab, 4CMenB, currently employed against meningococcal B. Studies by the Joint Committee on Vaccination and Immunisation (JCVI) indicate its effectiveness against gonorrhoea ranges between 32.7% and 42%. While it won't eradicate the infection entirely, vaccination promises to significantly diminish the risk of contracting it.

The JCVI further underscores the benefit of vaccination, given that prior gonorrhoea infections offer scant protection against subsequent ones. Moreover, the STI has become progressively harder to treat, exhibiting an alarming evolution of antibiotic resistance. Doctors are increasingly concerned that gonorrhoea could one day become completely untreatable.